Valneva Usa, INC.
At a glance
Employees20-99
In business sinceNot reported
HeadquartersBethesda, MD
US patents5
SAM.gov UEINT38AFWQNKM7
CAGE code43FM1
Incorporated inDE
- commercializes
- vaccines
- infectious diseases
- development
- U.S.A
Named on the company’s own website, read JUL 29, 2026
What they make
Open positions
Openings read from Valneva Usa, INC.’s own job board on Workable, last checked NOV 2, 2026. FactoryRegistry does not host applications — each title opens the posting where the company published it.
- Senior Occupational Health & Safety AdvisorLivingston, Scotland, United Kingdom · 12358 · posted OCT 28, 2026
- HR Analytics & Reporting Specialist (m/f/d)Vienna, Vienna, Austria · 11560 · posted OCT 27, 2026
- Senior Manager Lab CoordinationVienna, Vienna, Austria · 11231 · posted OCT 27, 2026
- Senior Engineer, Supply Chain (SCM)Solna, Stockholm County, Sweden · 13362 · posted OCT 23, 2026
- Deputy Head of Facility Management (f/m/d)Vienna, Vienna, Austria · 11811 · posted OCT 19, 2026
- PV Quality Assurance Manager (m/f/d)Vienna, Vienna, Austria · 11238 · posted OCT 19, 2026
- Technical Assistant QCVienna, Vienna, Austria · 11231 · posted OCT 14, 2026
- Deputy Responsible Pharmacist and Quality Assurance ManagerLyon, Auvergne-Rhône-Alpes, France · 18231 · posted SEP 18, 2026
- Senior MSL - Central TerritoryDallas, Georgia, United States · Remote · 14451 · posted SEP 8, 2026
- Senior MSL - East TerritoryMiami, Florida, United States · Remote · 14451 · posted SEP 8, 2026
Supplier designations
For Profit Organization
Self-certified by the company in its SAM.gov registration
Patents
5 US patents granted 2019–2025, 4 of them in the five years to SEP 2025.
Pharmaceuticals 5
- Isolated polypeptide of the toxin A and toxin B proteins of C. difficile and uses thereofUS 12,324,831 · granted JUN 10, 2025
- Isolated polypeptide of the toxin A and toxin B proteins of C. difficile and uses thereofUS 11,478,540 · granted OCT 25, 2022
- Isolated polypeptide of the toxin A and toxin B proteins of C. difficile and uses thereofUS 11,357,844 · granted JUN 14, 2022
- Isolated polypeptide of the toxin A and toxin B proteins of C. difficile and uses thereofUS 10,821,166 · granted NOV 3, 2020
- Isolated polypeptide of the toxin A and toxin B proteins of C. difficile and uses thereofUS 10,357,557 · granted JUL 23, 2019
Granted to Valneva USA, Inc. · PatentsView (USPTO), data through SEP 30, 2025 · CC BY 4.0
Their plant
| Facility | City | State | Employees | Status |
|---|---|---|---|---|
| Valneva Usa, INC. | Bethesda | MD | 20–99 | ACTIVE |
Compiled from federal records — EPA, OSHA, SAM.gov and the U.S. Census — and from the company’s own website. Federal source data is public domain. Each plant’s page names the source of every field.